Early markers of cardiovascular injury in childhood leukaemia survivors treated with anthracycline chemotherapy

Cardio-Oncology
Treya M LongLouise H Naylor

Abstract

Cardiovascular disease (CVD) is the leading non-malignant cause of death in childhood cancer survivors. Heightened risk of CVD is often attributable to treatment with anthracycline chemotherapy. Anthracycline-mediated cardiac injury may lie latent for years following cessation of treatment and is therefore often not detected until disease is advanced and aggressive therapy is required. Symptomatic CVD may be preceded by subclinical cardiac and vascular dysfunction. This study aimed to determine whether such dysfunction could be detected in healthy, anthracycline-treated survivors of childhood leukaemia. Cardiac magnetic resonance imaging (cMRI) with late gadolinium enhancement and endothelial function were used to characterise pre-clinical stages of CVD. Twenty-two long-term (>5 years survival; age 21 ± 3 years) childhood leukaemia survivors were assessed. All survivors were asymptomatic and had normal resting echocardiography. To exclude potential confounding effects of radiotherapy, no survivors had received this treatment. Twenty-two similarly aged (25 ± 3 years) gender-matched controls were recruited for comparison. Left ventricular ejection fraction was lower in the survivors (55.0 ± 4.6%) compared to the controls (59.4 ± ...Continue Reading

References

Mar 21, 1991·The New England Journal of Medicine·S E LipshultzS P Sanders
Nov 5, 1999·Journal of Magnetic Resonance Imaging : JMRI·R J van der Geest, J H Reiber
Sep 8, 2001·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·N G BellengerD J Pennell
Jul 19, 2002·Annals of Oncology : Official Journal of the European Society for Medical Oncology·L C M KremerP A Voûte
Nov 28, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven E LipshultzSteven D Colan
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jeffrey H SilberHuaqing Zhao
Apr 23, 2004·Leukemia & Lymphoma·András ZsáryIstván Karádi
Sep 4, 2004·RöFo : Fortschritte auf dem Gebiete der Röntgenstrahlen und der Nuklearmedizin·K OberholzerM Thelen
Dec 13, 2005·Biochimica Et Biophysica Acta·Matthew B Wolf, John W Baynes
Feb 7, 2006·European Journal of Echocardiography : the Journal of the Working Group on Echocardiography of the European Society of Cardiology·Roberto M LangUNKNOWN European Association of Echocardiography, European Society of Cardiology
Oct 13, 2006·The New England Journal of Medicine·Kevin C OeffingerUNKNOWN Childhood Cancer Survivor Study
Jun 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Joseph R CarverUNKNOWN ASCO Cancer Survivorship Expert Panel
Jan 8, 2008·Journal of Pediatric Hematology/oncology·Donald R DengelJames G Gurney
Feb 15, 2008·Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance·Nazanin Fallah-RadDavinder S Jassal
Mar 19, 2008·Heart·Steven E LipshultzRebecca E Scully
Sep 25, 2009·The New England Journal of Medicine·Hugo F FernandezMartin S Tallman
Feb 2, 2010·Journal of the American College of Cardiology·Daniela CardinaleCarlo M Cipolla
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven E Lipshultz, M Jacob Adams
Oct 19, 2010·American Journal of Physiology. Heart and Circulatory Physiology·Dick H J ThijssenDaniel J Green
Nov 9, 2010·Pediatric Blood & Cancer·Enrico De CaroGiacomo Pongiglione
Feb 19, 2011·Journal of the American College of Cardiology·Nathan MewtonJoão A C Lima
Jul 18, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory T ArmstrongScott D Flamm
Nov 21, 2013·Circulation. Cardiovascular Imaging·Paaladinesh ThavendiranathanThomas H Marwick
Mar 19, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gregory T ArmstrongKevin C Oeffinger
Nov 21, 2016·International Journal of Cardiology·Daniela Di LisiGiuseppina Novo
Jan 14, 2017·Circulation·Miranda M FidlerUNKNOWN British Childhood Cancer Survivor Study (BCCSS) Steering Group
Feb 28, 2017·Brain and Behavior·Ellen van der PlasBrian J Nieman
Sep 21, 2017·International Journal of Adolescent Medicine and Health·Treya M LongLouise H Naylor
May 8, 2018·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Adrián I Löffler, Michael Salerno
Jun 7, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Saro H ArmenianLeontien C M Kremer
Aug 11, 2018·JACC. Cardiovascular Imaging·Jennifer H JordanW Gregory Hundley

❮ Previous
Next ❯

Software Mentioned

SPSS
Siemens

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.

© 2021 Meta ULC. All rights reserved